All Sauce from Weekly Sauce:

The U.S. Food and Drug Administration (FDA) is reviewing the safety of mifepristone, a drug used in medication abortions for 25 years, amid a push from conservative state attorneys general and anti-abortion groups.  The announcement was made in a letter from Health and Human Services Secretary Robert F. Kennedy Jr, according to CBS News. The…  read on >  read on >

In-home firearm homicides of children and teenagers have more than doubled since 2010, according to a new study. Nearly a quarter of children and teenagers killed by guns died in their own homes between 2020 and 2021, including two-thirds of child victims 12 and under, according to findings published Sept. 26 in JAMA Surgery. These…  read on >  read on >

Teenagers and young adults turning to TikTok for sexual health advice would do well to make sure videos are produced by qualified health professionals, a new study says. More than 20% of sexual health-related TikToks created by non-medical influencers contained inaccurate info, researchers reported Sunday at the American Academy of Pediatrics’ annual meeting in Denver.…  read on >  read on >

More kids are being hurt in golf cart accidents, a new study says. Golf cart injuries among children have steadily increased over the past three years, researchers reported Sunday at the American Academy of Pediatrics’ annual meeting in Denver. Nine out of 10 kids injured are boys, and nearly half are younger than 12, researchers…  read on >  read on >

It sounds counterintuitive: Eat more fat and lose more weight. But it’s the underpinning of a keto diet — a controversial eating regimen designed to retrain the body to rely on something other than sugar for energy. The regimen is rich in meat, eggs, high-fat dairy and oils. “I think a lot of people look…  read on >  read on >

The maker of Tylenol is pushing back against resurfaced claims that its popular pain reliever is unsafe for pregnant women. Kenvue, the parent company of Tylenol, issued a statement Thursday after an old and now-deleted 2017 social media post resurfaced suggesting it did not recommend “any of our products while pregnant.”  The company now says…  read on >  read on >

A new gene therapy has shown promise in slowing the progression of Huntington’s disease, according to early trial results released Wednesday. In a Phase 1/2 study, patients given a high dose of UniQure’s experimental therapy AMT-130 experienced a 75% slowing of disease progression after three years, the company said. The therapy also reduced levels of…  read on >  read on >